ALG Manousakis Law Firm has contributed the Greek chapter to the 2025 edition of the Chambers Life Sciences Global Practice Guide.
Authored by Ioannis Manousakis (Managing Partner), Angela Livgieri (Junior Partner), Danai Panopoulou (Junior Associate), Dimitra Panopoulou (Junior Associate) and Iliana Andronou (Junior Associate), our chapter provides an in-depth analysis of the legal and regulatory framework governing the life sciences sector in Greece.
The Law Practice section covers key aspects of regulatory processes and requirements throughout the entire product life cycle, from clinical trials and manufacturing to marketing authorizations, distribution, and advertising, to pricing and reimbursement
The Trends and Developments section explores key issues shaping the pharmaceutical landscape in Greece. It highlights the government’s incentive scheme allowing claw-back offsets through R&D investments, promoting innovation and attracting industry funding. The piece also examines the steady increase in the use of generic medicines and the shift in public perception regarding their safety and effectiveness. Lastly, it outlines the recent wave of investment in pharmaceutical manufacturing facilities, positioning Greece as an emerging hub for production and research.
Our contribution aims to provide practical guidance and legal insight for stakeholders operating within this fast-evolving sector.